A multidisciplinary approach to the treatment of Anti-NMDA-receptor antibody encephalitis: A case and review of the literature

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 24, Issue 2, 2012, Pages 247-254

  Mann, Andrea ^a   Machado, Nikolas Mata ^a   Liu, Ni ^a   Mazin, Abdul Hussein ^a   Silver, Kenneth ^a   Afzal, Khalid I ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CARBIDOPA PLUS LEVODOPA; CEFTRIAXONE; CYCLOPHOSPHAMIDE; DIPHENHYDRAMINE; ETIRACETAM; IMMUNOGLOBULIN; LORAZEPAM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR ANTIBODY; PREDNISOLONE; RECEPTOR ANTIBODY; RISPERIDONE; RITUXIMAB; UNCLASSIFIED DRUG; VANCOMYCIN;

ADOLESCENT; ADULT DISEASE; AGE DISTRIBUTION; AGGRESSION; ANTI N METHYL D ASPARTATE RECEPTOR ENCEPHALITIS; ANTIBIOTIC THERAPY; ANTICONVULSANT THERAPY; ANTIVIRAL THERAPY; AUDITORY HALLUCINATION; CASE REPORT; CATATONIA; CEREBROSPINAL FLUID ANALYSIS; CHILDHOOD DISEASE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; DRUG WITHDRAWAL; ELECTROCONVULSIVE THERAPY; ELECTROENCEPHALOGRAPHY; FEMALE; HUMAN; IMMUNOTHERAPY; INSOMNIA; MUSCLE RIGIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANOIA; PATHOPHYSIOLOGY; PLASMAPHERESIS; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; REVIEW; SEX DIFFERENCE; TONIC CLONIC SEIZURE;

EID: 84865134837     PISSN: 08950172     EISSN: 15457222     Source Type: Journal    
DOI: 10.1176/appi.neuropsych.11070151     Document Type: Review

References (25)

1. Wandinger KP, Saschenbrecker S, Stoecker W, et al: Anti-NMDA-receptor encephalitis: a severe, multistage, treatable disorder presenting with psychosis. J Neuroimmunol 2011; 231:86-91
2. Irani SR, Bera K, Waters P, et al: N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 2010; 133:1655-1667
3. Dalmau J, Gleichman AJ, Hughes EG, et al: Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008; 7:1091-1098
4. Florance NR, Davis RL, Lam C, et al: Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol 2009; 66:11-18
5. Dalmau J, Tüzün E, Wu HY, et al: Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007; 61:25-36
6. Dalmau J, Lancaster E, Martinez-Hernandez E, et al: Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 2011; 10:63-74
7. Kleyensteuber B, Ruterbusch V, Bennett J, et al: Limbic encephalitis presenting with seizures, anterograde amnesia, and psychosis in a patient seven weeks status post-immature ovarian teratoma removal. Mil Med 2010; 175:616-618
8. Dalmau J, Bataller L: Clinical and immunological diversity of limbic encephalitis: a model for paraneoplastic neurologic disorders. Hematol Oncol Clin North Am 2006; 20:1319-1335
9. Iizuka T, Sakai F, Ide T, et al: Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Neurology 2008; 70:504-511
10. Lesher AP, Myers TJ, Tecklenburg F, et al: Anti-N-methyl-D-aspartate receptor encephalitis associated with an ovarian teratoma in an adolescent female. J Pediatr Surg 2010; 45:1550-1553
11. Dale RC, Irani SR, Brilot F, et al: N-methyl-D-aspartate receptor antibodies in pediatric dyskinetic encephalitis lethargica. Ann Neurol 2009; 66:704-709
12. Tan A, Shuey N, Bladin C: A modern perspective on the differential diagnosis between encephalitis lethargica or anti-NMDA-receptor encephalitis. JClin Neurosci 2010; 17:1204-1206
13. Gable MS, Gavali S, Radner A, et al: Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis. Eur J Clin Microbiol Infect Dis 2009; 28:1421-1429
14. Parratt KL, Allan M, Lewis SJ, et al: Acute psychiatric illness in a young woman: an unusual form of encephalitis. Med J Aust 2009; 191:284-286
15. Iizuka T, Yoshii S, Kan S, et al: Reversible brain atrophy in anti-NMDA receptor encephalitis: a long-term observational study. J Neurol 2010; 257:1686-1691
16. Brown EN, Lydic R, Schiff ND: General anesthesia, sleep, and coma. N Engl J Med 2010; 363:2638-2650
17. Poloni C, Korff CM, Ricotti V, et al: Severe childhood encephalopathy with dyskinesia and prolonged cognitive disturbances: evidence for anti-N-methyl-D-aspartate receptor encephalitis. Dev Med Child Neurol 2010; 52:e78-e82
18. Chapman MR, Vause HE: Anti-NMDA receptor encephalitis: diagnosis, psychiatric presentation, and treatment. Am J Psychiatry 2011; 168:245-251
19. Fink M, Taylor MA: The catatonia syndrome: forgotten but not gone. Arch Gen Psychiatry 2009; 66:1173-1177
20. Braakman HM, Moers-Hornikx VM, Arts BM, et al: Pearls and oysters: electroconvulsive therapy in anti-NMDA receptor encephalitis. Neurology 2010; 75:e44-e46
21. Lee A, Glick DB, Dinwiddie SH: Electroconvulsive therapy in a pediatric patient with malignant catatonia and paraneo-plastic limbic encephalitis. J ECT 2006; 22:267-270
22. Dhossche DM, Wachtel LE: Catatonia is hidden in plain sight among different pediatric disorders: a review article. Pediatr Neurol 2010; 43:307-315
23. American Psychiatric Association: Diagnostic criteria from DSM-IV-TR. Washington, D.C., American Psychiatric Association, 2000
24. Rey JM, Walter G: Half a century of ECT use in young people. Am J Psychiatry 1997; 154:595-602
25. Watkins CJ, Pei Q, Newberry NR: Differential effects of electroconvulsive shock on the glutamate receptor mRNAs for NR2A, NR2B, and mGluR5b. Brain Res Mol Brain Res 1998; 61:108-113